Cargando…
The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks
Allogeneic Hematopoietic stem cell transplantation (HSCT) is the most effective therapy to prevent relapse in acute lymphocytic leukemia (ALL). This benefit is affected by non-relapse mortality (NRM) due to complications such as graft versus host disease (GVHD). A new approach in analyzing time-depe...
Autores principales: | Jalali, Arash, Alimoghaddam, Kamran, Mahmoudi, Mahmood, Mohammad, Kazem, Mousavi, Seied Asadollah, Bahar, Babak, Vaezi, Mohammad, Zeraati, Hojjat, Jahani, Mohammad, Ghavamzadeh, Ardeshir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003436/ https://www.ncbi.nlm.nih.gov/pubmed/24800032 |
Ejemplares similares
-
The EBMT Risk Score in the Presence of Graft Versus Host Disease in Allogeneic Stem Cell Transplantation in Adult Acute Myelogenous Leukemia: A Multistate Model for Competing Risks
por: Jalali, Arash, et al.
Publicado: (2014) -
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Fanconi Anemia
por: Fumani, Hosein Kamranzadeh, et al.
Publicado: (2016) -
The Outcomes of Esophageal and Gastric Cancer Treatments in a Retrospective Study, Single Center Experience
por: Alimoghaddam, Kamran, et al.
Publicado: (2014) -
Conjugated Estrogen in Late-Onset Hemorrhagic Cystitis Associated with Hematopoietic Stem Cell Transplantation
por: Mousavi, Seyed Asadollah, et al.
Publicado: (2017) -
Long--Term Free Survival of Two Class III β-Thalassemic Patients after Non-Myeloablative Stem Cell Transplantation
por: Adib Sereshki, Mohammad Mahdi, et al.
Publicado: (2020)